Mercy Cancer Center has been offering a variety of clinical trials since 1983 so patients can access the latest cancer treatment drugs and methods right here, close to home.
Mercy is an active member of the following clinical trial groups:
- NCCTG - North Central Cancer Treatment Group
- NSABP - National Surgical Adjuvant Breast and Bowel Project
- CTSU - Cancer Trials Support Unit
- ECOG - Eastern Cooperative Oncology Group
In 1983, the National Cancer Institute (NCI) designated the Iowa Oncology Research Association (IORA) as a community clinical oncology program. Mercy Cancer Center is a member of the IORA. The IORA has worked diligently to provide Iowans with access to both cancer treatment and cancer prevention clinical trails.
Mercy Cancer Center currently participates in clinical trials for the treatment of the following cancers: brain, breast, colon, rectal, anal, esophageal, pancreatic, urologic, gastrointestinal, prostate, head and neck, lung, unknown cancers and hematology (blood cancers) including non-hodgkin's, mantle cell, ovarian, endometrial, myeloma, and leukemia.
Entry into a research study always is a joint decision between the physician and the patient. By looking at the pros and cons of clinical trials and other treatment choices, patients take an active role in life changing decisions. If you are interested in a research study, please ask your physician if this may be an option for you.
For more information about clinical trials, please contact the Mercy Cancer Center research office at 641-428-6304.